drugset / Trial / NCT03079271

An Open Label Comparing the Short Term Efficacy of Lacrisert

NCT03079271 ↗

Phase 4 Unknown 50 enrolled Virginia Eye Consultants
NaSingle-groupOpen-labelSupportive care

Summary

To evaluate the short term effects of LACRISERT®. upon fluorescein corneal staining, tear osmolarity and surface topography in human subjects with dry eye disease.

Timeline

Start
2016-11
Primary completion
2017-06
Completion
2017-12

Drugs

EvaluationDrugModalityDoseRoute
Subject HYDROXYPROPYL CELLULOSE Unknown 5 mg —

Indications